维普期刊资源整合服务平台（V6.5）

维普中文期刊产品整合服务

13篇 您的检索式：作者名="AMLER L C"

选中清除导出查看参考文献查看引证文献引用追踪共1页首页上一页第1页下一页末页 /1 跳转

		题名	作者	年代	出处	被引量
	1	Mutations in the epidermal growth factor receptor and in KRAS are predictive and prognostic indicators in patients with non small cell lung cancer treated with chemo- therapy alone and in combination with erlotinib 显示文摘	Eberhard D A Johnson B E Amler L C Goddard A D Heldens S L Herbst R S	2005	J Clin On- col2005，23，：	1
	2	Mutations in the epidermal growth factor receptor and in KRAS are predictive and prognostic indicators in patients with non-small-cell lung cancer treated with chemotherapy alone and in combination with erlotinib显示文摘	Eberhard D A Johnson B E Amler L C		0，，25：	1
	3	Muta- tions in the epidermal growth factor receptor and in KRAS are pre- dictive and prognostic indicators in patients with non-small-cell lung cancer treated with chemotherapy alone and in combination with erlotinib 显示文摘	EBERHARD D A JOHNSON B E AMLER L C	2005	J Clin Orwol2005，23，25：	1
	4	Mutations in the epidermal growth factor receptor and in KRAS are predictive and prognostic indicators in patients with non- small-cell lung cancer treated with chemotherapy alone and in combination with erlotinib 显示文摘	Eberhard D A Johnson B E Amler L C	2005	J Clin Oncol2005，25，：	1
	5	Mutations in the epidermal growth factor receptor and in KRAS are predictive and prognostic indicators in patients with non-small-cell lung cancer treated with chemotherapy alone and in combination with erlotinib显示文摘	EBERHARD D A JOHNSON B E AMLER L C	2005	J Clin Oncol2005，23，25：	1
	6	Mutations in the epider- mal growth factor receptor and in KRAS are predictive and prognostic indicators in patients with non-small-cell lung cancer treated with chemotherapy alone and in combination with erlotinib显示文摘	Eberhard D A Johnson B E Amler L C	2005	Journal of Clinical Oncology2005，23，25：	1
	7	Mutations in the epidermal growth factor receptor and in KRAS are predictive and prognostic indicators in patients with non-small-cell lung cancer treated with chemotherapy alone and in combination with erlotinib显示文摘	EBERHARD D A JOHNSON B Eo AMLER L C	2005	J Clin Oncol2005，23，25：	1
	8	Genomic instability in 1 p and human malignancies显示文摘	PRAML C AMLER L C	1996	Genes Chromosomes Cancer1996，16，：	1
	9	Mutation in the epidermal growth factor receptor and in KRAS are predictive and prognostic indicators in patients with non-small cell lung cancer treated with chemotherapy alone and in combination erlotinib显示文摘	Eberhard D A Johnson B E Amler L C	2005	J Clin Oncol2005，23，：	1
	10	Mutations in the epi- dermal growth factor receptor and in KRAS are predictive and prognos- tic indicators in patients with non-small-cell lung cancer treated with chemotherapy alone and in combination with erlotinib 显示文摘	Eberhard D A Johnson B E Amler L C	2005	J Clin On- col2005，23，25：	1
	11	Mutations in the epidermal growth factor receptor and in KRAS arepredictive and prognostic indicators in patients with non-small- cell lung cancer treated with chemotherapy alone and in combination with erlotinib显示文摘	Eberhard D A Johnson B E Amler L C	2010	J Clin Oncol2010，23，25：	1
	12	Clinical activity of gemcitabine plus pertuzumab in platinum-resistant ovarian cancer, fallopian tube cancer, or primary peritoneal cancer显示文摘	Makhija S Amler L C Glenn D	2010	J Clin Oncol2010，28，7：	1
	13	Mutations in the epidermal growth factor receptor and in KRAS are predictive and prognostic indicators in patients with non-small-cell lung cancer treated with chemotherapy alone and in combination with erlotinib显示文摘	Eberhard D A Johnson B E Amler L C	2005	J Clin Oncol2005，23，25：	1

返回顶部每页显示：

共1页首页上一页第1页下一页末页 /1 跳转

goolge学术搜索-维普

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1　渝公网安备 50019002500403号　违法和不良信息举报中心

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费